# Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome

> **NCT04647500** · NA · COMPLETED · sponsor: **University of Geneva, Switzerland** · enrollment: 45 (actual)

## Conditions studied

- 22q11.2 Deletion Syndrome

## Interventions

- **DRUG:** Concerta

## Key facts

- **NCT ID:** NCT04647500
- **Lead sponsor:** University of Geneva, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-26
- **Primary completion:** 2022-09-26
- **Final completion:** 2022-09-26
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647500, "Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04647500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*